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RESEARCH ARTICLE
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There is accumulating evidence that oxidative stress is an important contributor to carcino-
genesis. We hypothesized that genetic variation in genes involved in maintaining antioxi-
dant/oxidant balance would be associated with overall oxidative stress.
Methods
We examined associations between single nucleotide polymorphisms (SNPs) inMnSOD,
GSTP1, GSTM1,GPX1, GPX3, and CAT genes and thiobarbituric acid-reactive substances
(TBARS), a blood biomarker of oxidative damage, in healthy white women randomly
selected fromWestern New York (n = 1402). We used general linear models to calculate
age-adjusted geometric means of TBARS across the variants. We also examined the asso-
ciations within strata of menopausal status.
Results
ForMnSOD, being heterozygous was associated with lower geometric means of TBARS
(less oxidative stress), 1.28 mg/dL, compared to homozygous T-allele or homozygous C-
allele,1.35 mg/dL, and 1.31 mg/dL correspondingly (p for trend = 0.01). This difference
remained among postmenopausal women, 1.40 mg/dL for TT, 1.32 mg/dL for TC, and
1.34mg/dL for CC (p for trend 0.015); it was attenuated among premenopausal women.
SNPs in the other genes examined (GSTP1, GSTM1,GPX1, GPX3, and CAT) were not
associated with TBARS.
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Conclusions
Our findings suggest that genetic variation inMnSOD gene may be associated with oxida-
tive status, particularly among postmenopausal women.
Introduction
Reactive oxygen species (ROS) are by-products of metabolism which, in excessive amounts,
can initiate and promote carcinogenesis [1–3]. To manage the damaging effects of ROS, their
concentrations are controlled by the endogenous antioxidant defense system [4] that include
antioxidant enzymes (AOE) such as manganese superoxide dismutase (MnSOD), glutathione
peroxidases (GPx), catalase (CAT), and glutathione-S-transferases (GSTM1, GSTP1) [5, 6].
MnSOD, GPX1, GPX3, and CAT are involved in deactivation of the superoxide anion radical
and downstream ROS including hydrogen peroxide [3, 5]. GSTM1 and GSTP1 enzymes consti-
tute a second line of defense [5], which can detoxify electrophilic compounds that can cause
oxidative stress [7].
The activity of the AOEs is affected by single nuclear polymorphisms (SNPs) in these genes
[7–11]. Change in the activity of AOEs’ impacted by corresponding SNPs may influence oxida-
tive stress [12]. There have been numerous studies focused on the association between the
SNPs and risk of various pathological conditions associated with increased oxidative stress,
particularly cancer [13–23]. However, very few studies [12, 24] have been conducted to exam-
ine the relationship between genetic variation in these enzymes and oxidative stress biomark-
ers, specifically among healthy individuals.
Thiobarbituric acid-reactive substances (TBARS) is a biomarker of oxidative stress. The
TBARS spectrophotometric assay detects the concentration of a chromogen produced as a
result of a reaction between thiobarbituric acid and a product of lipid peroxidation, malondial-
dehyde (MDA)[25]. MDA has been widely used as a marker of oxidative stress [26]; for exam-
ple, it has been shown to be elevated among patients diagnosed with cancer compared to
healthy controls in some studies [27–29].
We examined the association between SNPs inMnSOD, GSTP1, GSTM1, GPX1, GPX3, and
CAT genes and TBARS in a randomly selected population-based sample of healthy women.
We hypothesized that SNPs in genes involved in maintaining antioxidant/oxidant balance
influence oxidative stress altering TBARS concentration.
Materials and Methods
TheWestern New York Exposures and Breast Cancer (WEB) study is a population-based
case-control study of breast cancer conducted between 1996 and 2001 [30]. The WEB study
included 2,115 healthy women as controls; data from the control women were used for this
analysis. Briefly, the women were 35 to 79 years of age residing in Erie and Niagara counties of
the state of New York, were fluent in English and had no history of cancer other than non-mel-
anoma skin cancer. Those less than 65 years of age were identified from the Department of
Motor Vehicles driver’s license lists; those ages 65 and older were randomly selected from the
rolls of the Health Care Financing Administration. Among eligible controls, 63% agreed to par-
ticipate in the study and provided informed consent. The protocol was reviewed and approved
by the Institutional Review Board of the University at Buffalo.
Participants completed comprehensive self-administered questionnaires and in-person inter-
views conducted by trained personnel. The data collected included demographics, smoking
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history and smoking status on the date of interview, and alcohol consumption, use of hormone
replacement therapy, and non-steroidal anti-inflammatory drugs 12 to 24 months prior to inter-
view. Body mass index was calculated based on height and weight measured during the inter-
view by trained interviewers using a standardized protocol and expressed in kg/m2.
Dietary intake of vitamins C and E were derived from a self-administered modified version
of the Health Habits and History food frequency questionnaire with the DietSys nutrient analy-
sis software (version 3.7). Dietary and supplement intake of the vitamins during 12 to 24
months prior to interview were used to obtain a total daily intake for each vitamin.
TBARSmeasurement
Blood for the analysis was drawn by trained phlebotomists on the morning of the interview,
between 7:30 am and 9:30 am, after at least 12 hours of fasting and at least 30 minutes after
smoking and physical exercise. For premenopausal women, the blood draw was done during
the luteal phase of menstrual cycle.
Plasma for TBARS assay was collected into 15%K3EDTA anticoagulant to chelate divalent
metal ions and prevent fenton type reactions. Samples were immediately wrapped in aluminum
foil to protect them from light, placed on wet ice, transferred to the specimen processing labo-
ratory and processed within 2 hours of collection [31].To prevent autooxidation during
TBARS assay, plasma samples (1 mL) were spiked with 10 uL of a 5% solution of Butylated
hydroxytoluene in methanol prior to analysis. The processed aliquots were then frozen at
-80°C. Plasma (15% K3 EDTA) TBARS, expressed in nmol/ml of malondialdehyde equivalents,
were measured in duplicate by the method of Armstrong and Browne [32]. Calibration stan-
dards and quality control (QC) samples were included in every run. QC samples were run in
duplicate and included three levels of “in-house” pooled human EDTA plasma, stored in ali-
quots at -80°C [33]. QC ranges were established from 20 determinations in the same run and
five samples per day over a period of 20 days. Levey-Jennings QC plots were employed to
track QC data across all participant samples and Westgard multirules were used to assess run
acceptability. The intra-and interassay coefficients of variation for TBARS were 7.6% and 9.2%
respectively across the study [34].
Genotyping
Blood was drawn from all consenting participants who agreed to provide samples (88% of con-
trols). The DNAQuik™ (BioServe, Beltsville, MD) extraction kit was used to obtain DNA from
blood cells.
We examined the following SNPs: rs4880 forMnSOD, rs1695 for GSTP1, rs1050450 for
GPX1, rs1946234 for GPX3, and rs1001179 for CAT genes. The SNPs for these analyses were
selected based on functional impact on the coded protein including variants which change the
sequence or expression of the protein. To determine the GSTP1_rs1695 genotype, the real-time
polymerase chain reaction (RT-PCR) Taqman allelic discrimination with pre-designed assays
(Applied Biosystems, Foster City, CA, USA) was utilized. The procedure was done according to
the manufacturer’s instructions. Genotyping of MnSOD_rs4880 (primers 5-ACGTTGGAT
GCTGTGCTTTCTCGTCTTCAG-3’ and 5’-ACGTTGGATGTTCTGCCTGGAGCCCAGATA-
3’), GPX1_rs1050450 (primers 5’-ACGTTGGATGATCCCGAGACAGCAGCA-3’ and 5’-
ACGTTGGATGATCGAGCCTGACATCGAAGC), GPX3_A13870C_rs1946234 (primers 5’-
ACGTTGGATGTGTTGCAGTTACTCTCTGGG-3’ and 5’-ACGTTGGATGACAAGTCATC
TAGCCAGAGC-3’), and CAT_rs1001179 (primers 5’- ACGTTGGATGAGCAATTGGA
GAGCCTCGC-3’ and 5’-ACGTTGGATGCTGAAGGATGCTGATAACCG-3’) was done utiliz-
ing polymerase chain reaction (PCR) followed by genotyping using the MassARRAY iPLEX™
SNPs and Oxidative Stress
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platform (Sequenom).The sequences of the primers were designed by utilizing SpectroDE-
SIGNER software (Sequenom), and the primers themselves were synthesized at BioServe Bio-
technologies, Ltd (Beltsville, MD). The Homogenous Mass Extend reaction was used to prepare
the PCR products for matrix-assisted laser desorption ionization-time of flight mass spectrome-
try (MALDI-TOFMS) [35]. Genotyping of GSTM1 was done utilizing TaqMan realtime PCR
with two 5-nuclease probes and four PCR primers according to the method described by Moore
et al. [36]. For GSTM1, the presence of deletion was determined.
Quality control procedures were identical for all SNPs and were performed for each labora-
tory assay and included positive and negative controls in all runs and samples analyzed as
blind duplicates (20%). All concordance rates were at least 91.7%, and call rates were above
93.7%.
Statistical analysis
Of 2,115 women in the study, there were 575 (508 white and 67 non-white women) with miss-
ing information on at least one genotype or a TBARS result, and so were excluded from these
analyses. Genotype distributions for each SNP (except for GSTM1) were tested for Hardy-
Weinberg equilibrium for the total group and the participants stratified by race (whites and
non-whites). Hardy-Weinberg equilibrium was violated for the CAT genotype among non-
white individuals (n = 138); to make the analysis more consistent, analyses were limited to
whites. Those who remained were less likely to be users of ibuprofen (42.4% vs.50.6%) and
more likely to be premenopausal (31.9% vs.25.8%) compared to the white participants
excluded on the basis of missing information on the exposures or outcome.
We examined the correlation between TBARS and age with the Spearman correlation.
Using general linear models, we calculated age-adjusted geometric means of TBARS across
all the variants. Additional adjustment for other factors which might be related to oxidation
including menopausal status, HRT use, number of hours of physical activity over the past
seven days, smoking status, secondhand smoke exposure, body mass index, alcohol consump-
tion, aspirin/ibuprofen consumption, education, and total intakes of vitamins C and E did not
change the estimates for more than 10%. These variables were not included in the final models.
We obtained the p-values for trend tests by modeling genotypes as continuous variables.
We also examined effect modification by menopausal status, exploring associations sepa-
rately for pre- and postmenopausal women.
The analyses were conducted using SAS 9.3 software. All the statistical tests were two-sided,
and level of significance was 5%.
Results
Demographic characteristics of the participants are presented in Table 1. Women were more
likely to be postmenopausal, never users of hormone replacement therapy, never/former smok-
ers, current drinkers, and non-users of aspirin. Concentration of TBARS was significantly asso-
ciated with age, but the association was not strong (Spearman correlation 0.20, p<0.001).
Blood concentration of TBARS was associated withMnSOD genotypes (Table 2). In the
overall sample, the age-adjusted geometric mean of TBARS was highest among those with the
TT genotype, 1.35 nmol/ml (p for trend = 0.01). After stratification based on menopausal sta-
tus, for postmenopausal women the value of the age-adjusted geometric mean of TBARS
remained the lowest among heterozygous individuals, 1.32 nmol/ml, compared to either TT-
or CC-genotypes, 1.40 nmol/ml and 1.34 nmol/ml correspondingly (p for trend = 0.015).
For premenopausal women, the geometric means of TBARS concentration did not differ
SNPs and Oxidative Stress
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considerably byMnSOD genotype, 1.25 nmol/ml for those with TT genotype, 1.21 nmol/ml for
those with TC genotype, and 1.22 nmol/ml for those with CC genotype (p for trend = 0.33).
SNPs in the other genes examined (GSTP1, GSTM1, GPX1, GPX3, and CAT) were not asso-
ciated with TBARS, either in the overall group or in strata defined by menopausal status.
Discussion
In a cross-sectional analysis, we found that genetic variation inMnSOD is associated with a
blood marker of oxidative stress, particularly among postmenopausal women. There were no
associations for the other SNPs studies for genes which play a role in control of oxidation.
Manganese superoxide dismutase is located in the mitochondria, converting the superoxide
anion radical resulting from the electron transport chain into oxygen and hydrogen peroxide
[3]. It has been hypothesized that the Ala (C-allele) variant may favor easier transport of the
MnSOD precursor into the mitochondria [8] and may result in higher basal activity of the
Table 1. Characteristics of the participants, WEB study controls, Erie and Niagara Counties, 1996–
2001a.
Characteristics All participants, n = 1402
Age (years) 56.6 (11.5)




Use of hormone replacement therapy
Never 868 (64.1)
Ever 486 (35.9)
Education (years) 13.4 (2.3)
Physical activity over the past 7 days (hours) 8.4 (10.1)
Smoking status
Never/former smoker 1193 (85.3)
Current smoker 206 (14.7)
Alcohol consumption
Lifetime/not current drinker 669 (48.2)
Current drinker 720 (51.8)
Aspirin use
Non-user (0 days/month) 767 (55.1)
Infrequent user (14 days/month) 454 (32.6)
Regular user (>14 days/month) 170 (12.2)
Ibuprofen
Non-user (0 days/month) 590 (42.5)
Infrequent user (14 days/month) 689 (49.6)
Regular user (>14 days/month) 111 (7.9)
Total daily vitamins intake
Vitamin C (mg) 174.1 (106.3–388.5)
Vitamin E (IU) 34.3 (8.9–221.4)
TBARSb (nmol/ml) 1.3(1.1–1.5)
aData shown are means (SD) for continuous variables; n (%) for categorical variables, and values of
median (interquartile range) for the total daily intake of vitamins C and E and for TBARS concentration.
bTBARS- Thiobarbituric acid-reactive substances
doi:10.1371/journal.pone.0156450.t001
SNPs and Oxidative Stress
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enzyme [37]. The Val-containing variant (T-allele), on the contrary, might become partially
arrested within the inner mitochondria membrane [8] impacting its function. However, in one
study it was found that individuals homozygous for the C-allele have lower MnSOD enzyme
activity compared to those with TC or TT genotypes [12]. Some studies have shown an associa-
tion of the C-allele with increased risk of certain cancers, particularly in homozygous individu-
als, compared to the individuals homozygous for the T-allele [13–17]. Our results suggest that
heterozygous individuals may have the greatest ability to cope with oxidative stress; those with
the TT genotype the lowest.
There is little previous research regarding the association between genetic variants and oxi-
dative stress biomarkers in a healthy population, and findings have not been consistent. Hong
et al. found that having at least one C-allele was associated with higher urine levels of 8-OH-
Table 2. Geometric means for TBARS byMnSOD,GSTP1, GSTM1,GPX1,GPX3, andCAT genotypes,
WEB study controls, Erie and Niagara counties, 1996–2001a.








TT 348 1.35(1.31–1.39) 117 1.25(1.19–1.31) 231 1.40(1.35–1.45)
TC 682 1.28(1.25–1.31) 222 1.21(1.17–1.25) 460 1.32(1.29–1.35)
CC 372 1.31(1.27–1.34) 108 1.22(1.16–1.28) 264 1.34(1.30–1.39)
p for trend 0.01 0.33 0.015
GSTP1
AA 661 1.31(1.28–1.33) 222 1.21(1.17–1.25) 439 1.35(1.32–1.39)
AG 593 1.31(1.28–1.33) 182 1.25(1.20–1.29) 411 1.34(1.30–1.37)
GG 148 1.29(1.24–1.35) 43 1.19(1.10–1.29) 105 1.34(1.27–1.41)
p for trend 0.91 0.34 0.71
GSTM1
Not null 584 1.31(1.28–1.34) 192 1.25(1.21–1.30) 392 1.34(1.30–1.37)
Null 818 1.30(1.28–1.32) 255 1.20(1.16–1.24) 563 1.35(1.32–1.38)
p for trend 0.52 0.07 0.60
GPX1
CC 654 1.31(1.28–1.33) 204 1.20(1.16–1.25) 450 1.36(1.32–1.39)
CT 621 1.30(1.27–1.33) 199 1.24(1.19–1.28) 422 1.33(1.30–1.36)
CC 127 1.32(1.26–1.38) 44 1.24(1.15–1.34) 83 1.36(1.29–1.44)
p for trend 0.79 0.53 0.49
GPX3
AA 1019 1.31(1.28–1.32) 331 1.22(1.19–1.26) 688 1.34(1.32–1.37)
AC 355 1.31(1.27–1.34) 109 1.22(1.16–1.28) 246 1.35(1.30–1.40)
CC 28 1.29(1.17–1.42) 7 1.10(0.90–1.33) 21 1.38(1.23–1.54)
p for trend 0.95 0.56 0.88
CAT
CC 848 1.31(1.28–1.33) 273 1.24(1.20–1.28) 575 1.34(1.31–1.37)
CT 491 1.31(1.27–1.34) 151 1.21(1.16–1.26) 340 1.35(1.32–1.39)
TT 63 1.24(1.17–1.33) 23 1.09(0.98–1.22) 40 1.33(1.23–1.45)
p for trend 0.36 0.07 0.80
aTBARS- Thiobarbituric acid-reactive substances
b adjusted for age
doi:10.1371/journal.pone.0156450.t002
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dG, a measure of oxidative DNA damage, compared to those homozygous for the T-allele [24].
It should be noted, however, that the study’s sample was small (n = 81) and consisted of term
pregnant women. Our sample consisted of non-pregnant women, and was larger. We found
that the association withMnSOD was limited to postmenopausal women. Menopause is char-
acterized by the drop of production of estrogens, hormones that can act as antioxidants [38,
39]. This loss of antioxidant defense by estrogen may result in higher oxidative stress among
postmenopausal women when compared to premenopausal women [38]. Premenopausal
women remain protected from oxidative stress by these hormones. In our study, the lack of
an association of theMnSOD genotype with TBARS among premenopausal women may be
related to their higher concentrations of circulating estrogen and estrogen metabolites, such
that the impact of genotype was not detectable.
Understanding of the strengths and limitations of this study are important in analysis of the
findings. There are some concerns with TBARS as a biomarker of oxidative status. TBARS is
not completely specific to malondialdehyde (MDA) and can be affected by reaction of the
assay with other compounds [3, 33]. These compounds may originate during lipid peroxida-
tion processes and may also impact the results of the test [40]. MDA in the sample can also be
formed through other mechanisms, not exclusively by lipid peroxidation [32]. Despite these
concerns, however, TBARS is a useful indicator of overall oxidative stress [33]. In fact, it has
been found to be elevated among cancer patients, individuals with an excessive oxidative stress
burden, compared to controls [41, 42].
Moreover, we examined a group of SNPs because of information regarding their functional
impact on the corresponding enzyme. It could be that other genetic variants in those genes or
other related genes are causally associated with TBARS. Given the complexity of the processes
to maintain oxidative balance, these analyses address only part of that process. Finally, oxida-
tive stress measured in blood may not be representative of reactions that take place on cellular
and sub-cellular levels. There might be different, even stronger associations with measures of
oxidative status in tissues. Further, the finding of an association of TBARS withMnSOD could
be the result of multiple testing. Further exploration of these associations in other samples
would be important in determining the consistency of the association.
This study does have some important strengths. These include the large sample size
(n = 1402) which allowed us to examine subgroups defined by menopausal status. The popula-
tion-based sample is also an advantage, allowing for external validity of the findings.
In conclusion, we found that oxidative stress may be associated with genetic variation in
MnSOD, particularly among postmenopausal women. Understanding of the factors both
endogenous and exogenous which impact oxidative status is critical to understanding oxida-
tion in chronic disease processes such as cardiovascular diseases and cancers. Our observations
need further exploration in order to better understand the role of ROS in the pathogenesis of
those chronic diseases.
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